Why Analytica’s PeriCoach is a Valuable First-Line Treatment for Urinary Incontinence

15th February 2016

A recent article on Bloomberg, which is getting global coverage, on the growth in the adult diaper market highlights the market need for an effective treatment for urinary incontinence – a condition that affects 1 in 3 women across the globe.

Urinary incontinence is caused by weakness to the pelvic floor muscles and is most commonly caused by trauma to the muscles during childbirth, but also exercise such as weights training.

For some time, women have used incontinence pads to address the condition and it appears this is on the increase. The Bloomberg article notes that sales of adult incontinence garments in the US could equal those of baby diapers in a decade, with pharmaceutical giants like Kimberly Clark targeting this lucrative adult segment of the market.

It states that: “Growth in the adult-diaper market is outpacing that of every other paper-based household staple in the U.S” with Euromonitor International forecasting “a 48 percent increase in sales in the category, to $2.7 billion in 2020 from $1.8 billion last year”.

Whilst diapers and pads are an increasingly popular option for women with urinary incontinence, they only address the symptoms and not the underlying cause of the condition. This condition is also linked to many quality of life issues and health conditions like depression, decreases in sexual satisfaction, obesity and diabetes.  Using pads encourages women to think that urinary incontinence is normal and can’t be treated, which is simply a fallacy.

However, by training their pelvic floor muscles correctly, women can address the problem. Analytica’s PeriCoach is a medical device that assists women to do pelvic floor exercises effectively.

Some PeriCoach customers have reported noticeable improvement in their continence in as little as two weeks, and have stopped using pads as quickly as two months.

PeriCoach is the only device that monitors pelvic floor muscle strength directly and captures and shares valuable data with patients and clinicians to monitor progress.  The PeriCoach system has FDA clearance in the US, TGA clearance in Australia and CE Marking for Europe.

Analytica’s studies and post-marketing surveys report women who use PeriCoach have reduced or eliminated urinary incontinence symptoms, feel dryer, more secure, more confident and experience the benefits of a stronger pelvic floor in various areas of their lives including sexual function.

For more information on Analytica and PeriCoach, please visit www.analyticamedical.com and www.pericoach.com